APPLIED SYNTHETIC MICROBIOTECHNOLOGY: Chapter 1: Biotechnological applications of bacteriophages
1. Introduction: bacteriophages
• Bacteriophages
o = viruses that infect bacteria
o Structure: capsid with genetic material, tailed (tail fibers, tail spikes) with injecting mechanism
o Kenmerk: bacteriophages are highly selective/specific for certain hosts (*)
• Lytic phage infection cycle: lytic phage
o 1) Adhesion and genome injection
▪ 1) Phage tail recognize specific receptors on target bacterial cellwall vb LPS, pilli, other OM
proteins (*) → reversible & irreversible binding on the bacterial surface
▪ 2) Then structural changes happen in phage particle → injection of genetic material
o 2) Expression of early genes
▪ Within minutes, early genes are expressed & early proteins are formed → early proteins
interact with the cell content vb with protein complexes → bacterial metabolism is
converted into virus producing machine
o 3) Genome replication of the bacteriophage
o 4) Generation & assembly of new phage particles
o 5) Release of new phages, by the action of enzymes degrading the cellwall
o Conclusion: 1 phage infecting a bacteria, self-amplificates, resulting in many more new phages
▪ Gevolg: local increase of phage particles at site of infection (phage therapy) or site of
diagnostic (diagnosis)
o Conclusion: bacteriophage infection happens within minutes-hours
• Lytic phage infection cycle: 1 step growth curve
o = Phages per cell vs time after infection (graph), including
▪ 1) Latent period
▪ 2) Burst size: the number of phages per cell formed, ifv time
o Dependent on
▪ 1) Specific growth conditions
▪ 2) The situation by which bacteria and phages coexist in an environment
▪ Vb: difference when using nutrient rich media ecological level
• Dynamic equilibrium/balance between bacteriophages & host cells/bacteria
o = the interaction between a bacteriophage & host cell may be parasitically , but will never be a full
eradication
▪ → especially in case of temperate phages (less with lytic phages)(zie hieronder)
▪ → this ecological struggle is reflected in diagnostics, microbial resistance development
• Lysogenic phage infection cycle: temperate phage
o 1) After genome injection, the phage’s genome can integrate into the bacterial genome
▪ → prophage = are bacteriophage genomes integrated into the host genome
▪ → gives a mutualistic interaction: benefit for both the bacteria & the phage
• 1) Phage genome is stably maintained & duplicates with the host genome
• 2) Bacteria has increasing virulence, by production of proteins encoded by the
prophage vb cholera toxin
• 3) Horizontal gene transfer of bacterial genes, happens through transduction, to
other bacteria → gives extra selection benefits to other bacteria
o 2) When stress (vb DNA stress), the mutualism ends → the prophage excises and enters the lytic
cycle → lysis of the host
2. Detection and typing of bacteria
1
,• Detection and typing of bacteria
o Bacteriophages are highly specific: most viruses will only attach to and infect a specific host
o Phage-typing
▪ = exploits this relationship & uses the virus as ‘tags’ to identify MO in the environment at the
sub-species level
▪ = to detect bacteria, bacterial pathogens etc. by exploiting phage specificity
o Host range of phage-typing: sub-species level, highly specific
▪ = within a species, the phages can vb only infect a subset of the isolates (adv & disadv)
▪ broad spectrum of antibiotics
o Phage-typing toepassing:
▪ 1) diagnostics: use a stable bank of phages to spot unknown bacteria & identify them at
subspecies level
▪ 2) fluorescently stained viruses (YOYO-1 or POPO-1) can be used as probes to label, identify,
and quantify specific strains of bacteria & cyanobacteria in mixed microbial assemblages.
• Major aspect of diagnostic assay: sensitivity vs specificity
• Example1: Luciferase Reporter Phage / Reporter phage assay
o 1) Phage infection:
▪ 1) Reporter genes (Lux, luc, ina or gfp) are inserted in the phage genome (engineered phage)
▪ 2) The recombinant DNA is packaged into phage particles
▪ 3) Reporter phage are mixed with the sample, but only infect susceptible host cells
• → removing the need for purification of the organism before detection
o 2) Phage replication: after infection, reporter phage genomes are replicated & reporter gene is
expressed from phage genome
o 3) Signal detection reporter protein accumulates → expression of reporter gene can be detected
o Sensitivity here = dependent on the amount of reporter protein present & capacity to detect it
o Specificity here = phage specifically recognizing its bacterial target
• Example2: Dual Phage Technology / Dual Phage Detection Assay (to improve specificity)
o → 2 different transducing phages: which transduce resistance genes to 2 different AB into a host cell
o → Antibodies chemically cross-linked to the 2 transducing phages
o 1) The antibody-labelled phages are mixed with the target antigen & allowed to bind
▪ Antibodies binding to the same target antigen cross-links the 2 transducing phages
o 2) This sample is mixed with host cells
▪ Only phages bound together via the target antigen, are brought in physical proximity, to co-
infect the host cells
▪ Sample mixing happened at a suitable dilution rate to ensure that random co-infection of
host cells is rare
o 3) Infected host cells are then grown on agar plates containing both antibiotics to select for only co-
infected cells
▪ Positive result = colonies on the agar plate
o Ab are not displayed on the phage, because full Ab’s are difficult to assemble → crosslink !
▪ only single chain camel Ab can be displayed on phages
o Increase of specificity by this assay because:
▪ 2 different phages with antibodies to different epitopes of the target antigen are used =
double detection selection method
• Other aspects of diagnostic assays: cost, time, reproducibility, stability
o Time: Mycobacterium tuberculosis grows very slow (up to 10 weeks) → to avoid this, use the PAA !!
• Example3: Phage Amplification Assay (PhaB assay) (increase in sensitivity??)
o → No modification of phages are required
o → There are phages infecting both M tuberculosis & M tuberculum smegmatis (belongs to same
family but grows rapidly), which we can use!
2
, o 1) Phage infection: Phages are mixed with the sample to infect susceptible cells (M. tuberculosis
present in the sample)
o 2) Once phage have entered the eclipse phase, a virucide is added
▪ The virucide does not affect the target bacterium, but external phages which have not
infected cells are destroyed → phages that have successfully infected the host, survive
o 3) The virucide is then neutralized & the sample containing the infected cells is mixed with helper
cells (M. Smegmatis) that support phage replication
▪ Helper cells don’t need to be the same cell type as the target bacterium
o 4) The mixture is spread over agar plates & incubated to develop a lawn
o 5) Phages in the infected cell, finish their replication, lyse the host cell & progeny phage infect the
rapidly growing helper cells (M. Smegmatis) in the lawn → leading to plaque formation
▪ Can count the nr of plaques formed & do back calculation
▪ Back calculation: if burst size of our phage in M. Smegmatis is 20 & we have 100 plaques →
back calculate using these 1 step growth curves, how many M. tuberculosis were present in
the original sample (in a day or 2, because M. Smegmatis grows rapidly)
• = based on the progeny of the 1st amplification round (?)
• Not on market yet
• Basic qpcr, pcr tecniques as diagnostics ara ctually be used in sensitivity way
• so terms of diagnostics, the qpcr type assays to quantify the bacteria offer a standard approach , but
• dunno opname?
• Example4: Bacteriophage Quantum Dots (to improve the sensitivity further) (not on market)
o = high-sensitivity bacterial detection using biotin-tagged phage and quantum-dot nanocomplexes
o Quantum dots
▪ = semiconducting nanocrystals ranging from 2-10 nanometers (10-50 atoms) in diameter
▪ → They strongly absorb light in the near UV range
▪ → They re-emit visible light with a color determined by both their size & surface chemistry
o 1) Phage Display using a biotinylation peptide fused to capsid protein (can become biotinylated)
o (2) After infection of the target bacterium (sample) with the phage → lysis
o (3) After lysis, the target bacterium (hosts) biotin-ligase protein will biotinylate the progeny phages
o (3) Then Quantum Dots conjugated to streptavidin are applied & interact with the biotinylated
progeny phages → labelled phages, and thus labelled bacteria are visible due to light emission of QD
o Kenmerken
▪ Detection limit 10 cells/ml
▪ 100 fold signal boost in 1h
o Increase of sensitivity by this assay because:
▪ → It uses the phage amplification step to get to low detection limits → so the light signal will
boost as time continues (more amplification)
o How do we produce phages that display the biotinylation peptide, but that not have been
biotinylated before by the production host?
▪ → by performing a KO of the host biotin-ligase protein in the production strain
3. Phage display and applications in antigen detection (no course material, just reminder)
• The Phage Display System
o Utilizes bacteriophage T7, which expose peptides fused to a capsid protein (by fusion of the coding
sequence of the peptide to capsid gene (or to other genes and displayed on other protein))
o Goal: way to find protein-protein interactions between exposed peptide & target protein in the well
o Kenmerken:
▪ Exposed polypeptides are accessible
▪ Viral particles are stable
▪ Amplification possible
3
, ▪ Protein exposed (on the phage) and gene (inside the phage) are linked
o Traditional exposition using filamentous ssDNA phage M13 (zie ppt)
• Application of phage display: Tissue-specific peptide identification
o 1) Extensive phage libraries, each displaying different peptides → injection in mouse
o 2) Then you can see if there are certain phage particles (& their peptides) specifically recognizing
certain types of tissues vb binding to receptors on mouse lung → peptide sequencing
4. Bacteriophages as vaccins / DNA vaccin
• 1) Bacteriophages as vaccins (protein vaccins)
o 1) Bacteriophages exposing an antigen peptide originating from the disease-causing microorganism
are injected into the blood stream (= phage display)
o 2) B cells in the blood stream respond to the antigen by producing antibodies & memory cells
o 3) The antibodies bind to the antigen to "neutralize"or inactivate it (so also when exposed again)
o Due to its innate immunogenic properties, the proteins from the phage particles act as natural
adjuvant, thus stimulating and improving the immune response!
o Exposition (phage display) through
▪ 1) transcriptional fusion of coat protein to the coding sequence of the antigen
▪ 2) or by artificial conjugation to phage surface (e.g. galactose, succinic acid)
o Advantage: these phage particles are very cheap to produce & stable
• 2) Bacteriophages as DNA-vaccins (DNA vaccins)
o DNA-vaccination (or DNA plasmid vector vaccination)
▪ = the vaccin carries the genetic material encoding protective antigens → the antigen can
then be produced inside the host cell → which stimulate a cell-mediated immune response
(via the MHC1 pathway) → which provide protection against pathogens
▪ = carries the genetic code for a piece of pathogen of tumor antigen
o 1) The plasmid vector is taken up into cells and transcribed in the nucleus
o 2) The single stranded mRNA is translated into protein in the cytoplasm.
o 3) The DNA vaccine-derived protein antigen is then degraded by proteosomes into intracellular
peptides.
o 4) The vaccine derived-peptide binds MHC class I molecules.
o 5) Peptide antigen/MHC I complexes are presented on the cell surface, binding cytotoxic CD 8+
lymphocytes, and inducing a cell-mediated immune response.
o Advantage:
▪ Cheaper & easier to produce than protein vaccins
▪ Packaging the DNA into phage particles improves the DNA stability & uptake
o Disadvantage:
▪ 1) less advense effect
▪ 2) induction of cellular and humoral immune system
▪ 3) less efficient in large animals => resolving these problems increase cost & technical issues
o Opm: Since DNA vaccines generate cell-mediated immunity, the hope is that they will be effective
against some difficult viruses where standard vaccines have failed to work.
• Bacteriophages as DNA-vaccins
o Cloning of DNA vaccines into bacteriophages (e.g. lambda, T7, M13)
▪ gene under control of eukaryotic promoter (e.g. CMV)
▪ DNA is packaged in vitro
▪ easy propagation in an E. coli host
▪ phage protein coat protects the DNA
▪ phage (with the DNA) is taken up by antigen presenting cells
o In Rabbits: lambda –HBsAg (2 µg DNA) (linear pRcCMV-HBs(S)
o Kenmerken:
4
The benefits of buying summaries with Stuvia:
Guaranteed quality through customer reviews
Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.
Quick and easy check-out
You can quickly pay through credit card for the summaries. There is no membership needed.
Focus on what matters
Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!
Frequently asked questions
What do I get when I buy this document?
You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.
Satisfaction guarantee: how does it work?
Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.
Who am I buying these notes from?
Stuvia is a marketplace, so you are not buying this document from us, but from seller feline2. Stuvia facilitates payment to the seller.
Will I be stuck with a subscription?
No, you only buy these notes for £8.56. You're not tied to anything after your purchase.